Stephen DuBois
@Camber Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$3.149BTotal holdings33
Assets growth rate-12.86%Assets growth rate (2-Q avg)-12.15%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Camber Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 33 positions.
Assets under management
The assets under management (AUM) of Camber Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.149B in assets, with a quarterly growth rate of -12.86% and a 2-quarter average growth rate of -12.15%. The portfolio is managed by Stephen DuBois, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MEDPMedpace Hldgs Inc
| 1.33% | $41.725M 125,000 shares@ $333.8 avg price | New Position |
EVHEvolent Health Inc
| 1.26% | $39.592M 1.4M shares@ $28.28 avg price | Increased 124% |
UHSUniversal Hlth Svcs Inc
| 0.91% | $28.626M 125,000 shares@ $229.01 avg price | Decreased -86.84% |
1124⤦Brookdale Sr Living Inc
| 0.74% | $23.089M 250,000 shares@ $92.36 avg price | |
MLTXMoonlake Immunotherapeutics
| 0.71% | $22.235M 441,000 shares@ $50.42 avg price | Increased 24.23% |
HLFHerbalife Ltd
| 0.69% | $21.57M 3M shares@ $7.19 avg price | |
BCYCBicycle Therapeutics Plc
| 0.66% | $20.706M 915,000 shares@ $22.63 avg price | |
INGNInogen Inc
| 0.62% | $19.4M 2M shares@ $9.7 avg price | |
OSUROrasure Technologies Inc
| 0.58% | $18.148M 4.25M shares@ $4.28 avg price | |
TBPHTheravance Biopharma Inc
| 0.26% | $8.06M 1M shares@ $8.06 avg price |